Back
Cartesian Therapeutics Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
37
RNAC
Cartesian Therapeutics
Last Price:
$13.54
Seasonality Move:
-1.08%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RNAC is experiencing buying pressure, which is a positive indicator for future bullish movement.
Cartesian Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 12.57 | Buy |
20-day SMA: | 11.31 | Buy |
50-day SMA: | 10.63 | Buy |
200-day SMA: | 16.09 | Sell |
8-day EMA: | 10.32 | Buy |
20-day EMA: | 5.94 | Buy |
50-day EMA: | 2.8 | Buy |
200-day EMA: | 0.76 | Buy |
Cartesian Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.5 | Buy |
Relative Strength Index (14 RSI): | 66.18 | Buy |
Chaikin Money Flow: | 63328 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9.91 - 12.39) | Buy |
Bollinger Bands (100): | (9.54 - 15.58) | Buy |
Cartesian Therapeutics Technical Analysis
Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Cartesian Therapeutics Stock
Is Cartesian Therapeutics Stock a Buy?
-
Cartesian Therapeutics share price is 13.58 while RNAC 8-day simple moving average is 12.57, which is a Buy signal.
-
The stock price of RNAC is 13.58 while Cartesian Therapeutics 20-day SMA is 11.31, which makes it a Buy.
-
Cartesian Therapeutics 50-day simple moving average is 10.63 while RNAC share price is 13.58, making it a Buy technically.
-
RNAC stock price is 13.58 and Cartesian Therapeutics 200-day simple moving average is 16.09, creating a Sell signal.
RNAC Technical Analysis vs Fundamental Analysis
Sell
37
Cartesian Therapeutics (RNAC)
is a Sell
Is Cartesian Therapeutics a Buy or a Sell?
-
Cartesian Therapeutics stock is rated a SellThe current Cartesian Therapeutics [RNAC] share price is $13.58. The Score for RNAC is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
Cartesian Therapeutics Stock Info
Market Cap:
352.5M
Price in USD:
13.58
Share Volume:
67K
Cartesian Therapeutics 52-Week Range
52-Week High:
26.50
52-Week Low:
8.46
Sell
37
Cartesian Therapeutics (RNAC)
is a Sell
Cartesian Therapeutics Share Price Forecast
-
What is the Cartesian Therapeutics stock price today?The Cartesian Therapeutics stock price is 13.58 USD today.
-
Will RNAC stock go up or go down?Cartesian Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Cartesian Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Cartesian Therapeutics is overvalued.
Is Cartesian Therapeutics Stock a Buy?
-
Cartesian Therapeutics share price is 13.58 while RNAC 8-day exponential moving average is 10.32, which is a Buy signal.
-
The stock price of RNAC is 13.58 while Cartesian Therapeutics 20-day EMA is 5.94, which makes it a Buy.
-
Cartesian Therapeutics 50-day exponential moving average is 2.80 while RNAC share price is 13.58, making it a Buy technically.
-
RNAC stock price is 13.58 and Cartesian Therapeutics 200-day simple moving average is 0.76, creating a Buy signal.
Fundamental Analysis of Cartesian Therapeutics
Is Cartesian Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.83 per share, and an increase next year of $0.35 per share.
Technical Analysis of Cartesian Therapeutics
Should I short Cartesian Therapeutics stock?
-
RNAC Moving Average Covergence Divergence (MACD) indicator is 3.5, suggesting Cartesian Therapeutics is a Buy
-
Cartesian Therapeutics Relative Strength Index (RSI) is 66.18, which suggest Cartesian Therapeutics is overbought
-
The Bollinger Bands (25) for Cartesian Therapeutics is (9.91 - 12.39), which suggest Cartesian Therapeutics is a Buy
-
The Bollinger Bands (100) for Cartesian Therapeutics is (9.54 - 15.58), which suggest Cartesian Therapeutics is a Buy
* Cartesian Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.